Susceptibility to new β-lactams of enterobacterial extended-spectrum β-lactamase (ESBL) producers and penicillin-resistant Streptococcus pneumoniae in Mexico

Journal of Chemotherapy

Volumn 10, Issue 2, 1998, Pages 102-107

  Silva, J ^a,c   Aguilar, C ^a   Estrada, M A ^a   Echaniz G ^b   Carnalla, N ^b   Soto, A ^b   Lopez Antunano F J ^c  

^a Ctro Invest Fijacion Nitrogeno U   (Mexico)

^b Depto de Diagnostico Epidemiologico   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Antibiotic; Cefepime; Cefpirome; Enterobacteria; ESBL; Extended spectrum betalactamase producers; Penicillin resistant; Resistance; Streptococcus pneumoniae; Susceptibility

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENZYME ACTIVITY; ESCHERICHIA COLI; HOSPITAL; HUMAN; KLEBSIELLA PNEUMONIAE; MEXICO; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0031897011     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1998.10.2.102     Document Type: Article

References (20)

1. Jacoby GA, Medeiros AA. More extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991; 35: 1697-1704.
2. Payne D, Amyes SGB. Transferable resistance to extended-spectrum β-lactams: a major threat or a minor inconvenience? J Antimicrob Chemother 1991; 27: 255-261.
3. Sougakoff W, Goussard S, Gerbau G, Courvalin P. Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes. Rev Infect Dis 1988; 1: 879-884.
4. Berman S. Epidemiology of acute respiratory infectious in children in developing countries. Rev Infect Dis 1991; 13(supp 16): S454-62.
5. Baquero F. Pneumococcal resistance to β-lactam antibiotics: A global geographic overview. Microb Drug Resist 1995; 2: 115-120.
6. Osano E, Arakawa Y, Wacharotayankun R, et al. Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 1994; 38: 71-78.
7. Watanabe M, lyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991; 35: 147-151.
8. Redjeb SB, Yaghlane YH, Boujnah A, Philippon A, Labia R. Synergy between clavulanic acid and newer β-lactams on nine clinical isolates of Klebsiella pneumonia, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins. J Antimicrob Chemother 1988; 21: 263-266.
9. Silva J, Aguilar C. β-Lactamase bioassay: A simplified method to determine extended-spectrum β-lactamases (ESBL) in enterobacteria. Arch Med Res 1997; 28: 285-287.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards. Villanova. Pa. 1997.
11. Silva J, Aguilar C, Becerra Z, Conde C, García R, Fuchs Y. Resistance to broad spectrum cephalosporins harboured in plasmids among clinical isolates of enterobacteria. Recent Advances in Chemotherapy. Proceedings of 18th International Congress of Chemotherapy. American Society for Microbiology, Washington, D.C. 1993: 505-506.
12. Jacoby GA, Carreras I. Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1995; 34: 858-862.
13. Jett BD, Ritchie DJ, Reichley R, Baileym TC, Sahm DF. In vitro activities of various β-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins. Antimcrob Agents Chemother 1995; 39: 1187-1190.
14. Finch RG. Pneumonia: The impact of antibiotic resistance on its management. Microb Drug Resist 1995; 1: 149-158.
15. Echéniz AG, Velázquez MM, Carnalla BN, et al. Antimicrobial susceptibilities and capsular types of invasive Streptococcus pneumoniae isolated in children in Mexico City. Microb Drug Resist 1997; 3: 153-157.
16. Spangler SK, Jacobs MR, Appelbaum PC. Susceptibilities of 177 penicillin-susceptible and resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem and vancomycin. Antimicrob Agents Chemother 1994; 38: 898-900.
17. Appelbaum PC. New prospects for antibacterial agents against multidrug-resistant pneumococci. Microb Drug Resist 1995; 1: 43-48.
18. Nielsen SV, Henrichsen J. Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987. Clin Infect Dis 1992; 15: 794-798.
19. Muñoz R, Coffey T, Daniels M, et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991; 164: 302-306.
20. López-Antuñano FJ, Silva J. Bacterial resistance to antibiotics in acute respiratory infections (ARIs). Arch Med Res 1997; 28(2): 195-203.